Insulin resistance and type 2 diabetes are independent risk factors for cardiovascular diseases. Levels of C-peptide are increased in these patients and its role in the atherosclerosis progression was studied in vitro and in vivo over the past years. To evaluate the possible use of C-peptide as cardiovascular biomarkers, we designed an observational study in which we enrolled patients with mono- or poly-vascular atherosclerotic disease.
Cardellini, M., Farcomeni, A., Ballanti, M., Morelli, M., Davato, F., Cardolini, I., et al. (2017). C-peptide: A predictor of cardiovascular mortality in subjects with established atherosclerotic disease. DIABETES & VASCULAR DISEASE RESEARCH [10.1177/1479164117710446].
C-peptide: A predictor of cardiovascular mortality in subjects with established atherosclerotic disease
CARDELLINI, MARINA;FARCOMENI, ALESSIO;BALLANTI, MARTA;Morelli, M;DAVATO, FRANCESCA;RIZZA, STEFANO;PORZIO, OTTAVIA;PECCHIOLI, CHIARA;MENGHINI, ROSSELLA;IPPOLITI, ARNALDO;FEDERICI, MASSIMO
2017-05-01
Abstract
Insulin resistance and type 2 diabetes are independent risk factors for cardiovascular diseases. Levels of C-peptide are increased in these patients and its role in the atherosclerosis progression was studied in vitro and in vivo over the past years. To evaluate the possible use of C-peptide as cardiovascular biomarkers, we designed an observational study in which we enrolled patients with mono- or poly-vascular atherosclerotic disease.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
